Prohance and anaphylactic shock Patient Reports February 13, 2012

Prohance Side Effects Report #5627055-0
Prohance side effect was reported by a Health Professional from UNITED STATES on June 14, 2007. Female patient, 31 years of age, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Prohance. After drug was administered, patient experienced the following side effects: anaphylactic shock. Prohance dosage: 20 ML ONCE IV. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #4559731-5
Prohance side effect was reported by a Health Professional from on Mar 04, 2004. Female patient, 28 years of age, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Prohance. After drug was administered, patient experienced the following side effects: abdominal pain , anaphylactic shock. Prohance dosage: 6 ML ONCE IV. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #5288924-7
Prohance side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 28, 2006. Female patient, 77 years of age, weighting 136.7 lb, was diagnosed with nuclear magnetic resonance imaging, spindle cell sarcoma and was treated with Prohance. After drug was administered, patient experienced the following side effects: anaphylactic shock. Prohance dosage: 13 ML ONCE IV. During the same period patient was treated with ATENOLOL, ALLOPURINOL, PRAVACHOL. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #5601345-X
Prohance side effect was reported by a Health Professional from JAPAN on Jan 22, 2008. Male patient, 68 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: anaphylactic shock, arteriospasm coronary, blood pressure immeasurable, bradycardia, electrocardiogram st segment elevation, flushing, hyperhidrosis, hypoaesthesia, myocardial ischaemia. Prohance dosage: unknown. During the same period patient was treated with ATROPIN, SIGMART, OXYGEN. Patient was hospitalized. Patient recovered.


Prohance Side Effects Report #5610798-2
Prohance side effect was reported by a Health Professional from JAPAN on Jan 28, 2008. Male patient, 68 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: acute myocardial infarction, anaphylactic shock, hypoaesthesia. Prohance dosage: unknown. During the same period patient was treated with ATROPIN, SIGMART, OXYGEN. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #5620035-0
Prohance side effect was reported by a Health Professional from JAPAN on Feb 06, 2008. Male patient, 68 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: anaphylactic shock. Prohance dosage: unknown. During the same period patient was treated with ATROPIN, SIGMART, OXYGEN. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #6032911-8
Prohance side effect was reported by a Physician from UNITED STATES on Jan 17, 2008. Female patient, 54 years of age, weighting 158.3 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: anaphylactic shock, respiratory distress. Prohance dosage: 15ML QD INTRAVENOUS. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #5288921-1
Prohance side effect was reported by a Health Professional from UNITED STATES on Oct 30, 2006. Female patient, 69 years of age, was diagnosed with intermittent claudication, nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: anaphylactic shock. Prohance dosage: 40 ML ONCE IV. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #5042925-2
Prohance side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Female patient, 31 years of age, weighting 127.9 lb, was diagnosed with induration and was treated with Prohance. After drug was administered, patient experienced the following side effects: anaphylactic shock, electrocardiogram qt corrected interval prolonged. Prohance dosage: unknown. Patient was hospitalized. Patient recovered.


Prohance Side Effects Report #5033968-3
Prohance side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Female patient, 31 years of age, weighting 127.9 lb, was diagnosed with induration and was treated with Prohance. After drug was administered, patient experienced the following side effects: anaphylactic shock, electrocardiogram qt corrected interval prolonged. Prohance dosage: unknown. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #4946148-4
Prohance side effect was reported by a Health Professional from UNITED STATES on Mar 08, 2005. Female patient, 34 years of age, was diagnosed with headache , neck pain, nuclear magnetic resonance imaging brain and was treated with Prohance. After drug was administered, patient experienced the following side effects: anaphylactic shock. Prohance dosage: 15 ML ONCE IV. Patient recovered.

Prohance Side Effects Report #5594544-7
Prohance side effect was reported by a Physician from JAPAN on Jan 15, 2008. Male patient, 63 years of age, weighting 88.18 lb, was diagnosed with diagnostic procedure, brain neoplasm, sedation and was treated with Prohance. After drug was administered, patient experienced the following side effects: anaphylactic shock, respiratory depression. Prohance dosage: unknown. During the same period patient was treated with LACTEC, DORMICUM, PENTAGIN, VASOPRESSIN AND ANALOGUES. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #5605622-8
Prohance side effect was reported by a Physician from JAPAN on Jan 23, 2008. Male patient, 63 years of age, weighting 88.18 lb, was diagnosed with diagnostic procedure, brain neoplasm, sedation, pain  and was treated with Prohance. After drug was administered, patient experienced the following side effects: anaphylactic shock, respiratory depression. Prohance dosage: unknown. During the same period patient was treated with LACTEC, DORMICUM, PENTAGIN, VASOPRESSIN AND ANALOGUES. Patient was hospitalized. Patient recovered.